| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Magnesium dust |
Is a |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium fumes |
Is a |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium isotope |
Is a |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium measurement, urine |
Has measured component (attribute) |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium measurement |
Has measured component (attribute) |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium measurement, serum |
Has measured component (attribute) |
False |
Magnesium |
Inferred relationship |
Some |
|
| Blood magnesium measurement |
Has measured component (attribute) |
False |
Magnesium |
Inferred relationship |
Some |
|
| Plasma magnesium measurement |
Has measured component (attribute) |
False |
Magnesium |
Inferred relationship |
Some |
|
| 24 hour urine magnesium output measurement |
Has measured component (attribute) |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium measurement, urine |
Component |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium measurement |
Component |
True |
Magnesium |
Inferred relationship |
Some |
1 |
| Magnesium measurement, serum |
Component |
False |
Magnesium |
Inferred relationship |
Some |
2 |
| Blood magnesium measurement |
Component |
False |
Magnesium |
Inferred relationship |
Some |
2 |
| Plasma magnesium measurement |
Component |
False |
Magnesium |
Inferred relationship |
Some |
2 |
| 24 hour urine magnesium output measurement |
Component |
False |
Magnesium |
Inferred relationship |
Some |
|
| Red cell magnesium measurement (procedure) |
Component |
False |
Magnesium |
Inferred relationship |
Some |
2 |
| Magnesium amino acids chelate |
Is a |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium chloride hexahydrate |
Is a |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium electrolyte (substance) |
Is a |
True |
Magnesium |
Inferred relationship |
Some |
|
| Medicinal product acting as magnesium supplement (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Aluminium hydroxide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Aluminum hydroxide oral suspension BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing precisely aluminium hydroxide 475 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium carbonate mixture BPC |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Aromatic magnesium carbonate mixture BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Compound magnesium trisilicate 250 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium trisilicate mixture BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium trisilicate powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Compound magnesium trisilicate oral powder BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Hydrotalcite 100 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium carbonate compound tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium carbonate compound powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Aluminum hydroxide+belladonna mixture |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium trisilicate+belladonna 0.15mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium sulfate powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Aluminum only antacids |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Antacids containing aluminum and magnesium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Co-magaldrox product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing hydrotalcite (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium hydroxide mixture BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Co-simalcite |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing precisely magnesium hydroxide 83 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing magnesium trisilicate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing magaldrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium-based antacid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing magnesium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing magnesium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing aluminium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Aluminum hydroxide [antacid] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magaldrate 800mg/5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium hydroxide [laxative] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Aluminum hydroxide [nutritional use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium chloride 200mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Aluminum hydroxide+belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing belladonna and magnesium trisilicate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Simethicone + hydrotalcite 125mg/500mg oral suspension sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Liquid paraffin+magnesium hydroxide oral emulsion BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Calculus magnesium content measurement (procedure) |
Component |
False |
Magnesium |
Inferred relationship |
Some |
2 |
| Calcium and magnesium product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Magnesium measurement, urine |
Component |
False |
Magnesium |
Inferred relationship |
Some |
2 |
| 24 hour urine magnesium output measurement |
Component |
False |
Magnesium |
Inferred relationship |
Some |
2 |
| Co-simalcite suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing magaldrate and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing aluminium hydroxide and magnesium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing alginic acid and aluminium hydroxide and magnesium trisilicate and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing aluminium hydroxide and magnesium hydroxide and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing calcium and magnesium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Magnesium |
Inferred relationship |
Some |
2 |
| Product containing magnesium malate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing precisely magnesium malate 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Fluid sample magnesium measurement (procedure) |
Component |
False |
Magnesium |
Inferred relationship |
Some |
2 |
| Magnesium / creatinine ratio measurement (procedure) |
Component |
False |
Magnesium |
Inferred relationship |
Some |
2 |
| Plasma adjusted magnesium measurement (procedure) |
Component |
False |
Magnesium |
Inferred relationship |
Some |
2 |
| Serum adjusted magnesium measurement (procedure) |
Component |
False |
Magnesium |
Inferred relationship |
Some |
2 |
| Adjusted magnesium measurement (procedure) |
Component |
True |
Magnesium |
Inferred relationship |
Some |
1 |
| Product containing precisely magaldrate 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing calcium carbonate and famotidine and magnesium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing aluminium hydroxide and magnesium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing hydrotalcite and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing citric acid and magnesium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing magnesium oxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing magnesium hydroxide and mineral oil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing magnesium carbonate and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing activated charcoal and magnesium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing magnesium carbonate and magnesium trisilicate and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing calcium carbonate and magnesium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing aluminium oxide and magnesium hydroxide and oxetacaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing magnesium hydroxide and omeprazole and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing precisely magnesium hydroxide 700 milligram and omeprazole 20 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium |
Inferred relationship |
Some |
|
| Measurement of fractional excretion of magnesium using urine specimen and serum or plasma specimen (procedure) |
Component |
False |
Magnesium |
Inferred relationship |
Some |
3 |
| Increase or decrease in magnesium content of the diet. |
Direct substance |
True |
Magnesium |
Inferred relationship |
Some |
1 |
| Increase in magnesium content of the diet compared to the assessed baseline intake of magnesium for the individual. |
Direct substance |
True |
Magnesium |
Inferred relationship |
Some |
1 |
| Decrease in magnesium content of the diet compared to the assessed baseline intake of magnesium for the individual. |
Direct substance |
True |
Magnesium |
Inferred relationship |
Some |
1 |
| Providing magnesium based on suboptimal food or fluid intake, iatrogenic deficiency or medical diagnosis. |
Direct substance |
False |
Magnesium |
Inferred relationship |
Some |
1 |
| Product containing magnesium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Magnesium |
Inferred relationship |
Some |
1 |
| Calcium and magnesium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Magnesium |
Inferred relationship |
Some |
2 |
| Product containing only magnesium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Magnesium |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]